Prevail Therapeutics Inc. Share Price
Equities
PRVL
US74140Y1010
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 01/18/01 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/18/01 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 01/18/01 |
1st Jan change | Capi. | |
---|---|---|
-2.58% | 103B | |
+1.73% | 95.28B | |
+1.46% | 22.15B | |
-15.64% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.75% | 16.05B | |
+5.68% | 13.68B | |
+34.58% | 12.17B |